Monitor the safety and tolerability of efavirenz oral solution in combination with
Antiretroviral Therapy for the treatment of patients age 3 to 16 years who have failed
therapy or who are intolerant to their current therapy.
This is an early phase trial and some specific protocol information is in progress and not
publicly available at this time. (Full information is available to trial participants).